Reducing the Risk of Preventable Adverse Drug Events associated with Hypoglycemia in the Older Population
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, Professional Affairs and Stakeholder Engagement Staff (PASES), is hosting a one day public workshop entitled “Reducing the Risk of Preventable Adverse Drug Events associated with Hypoglycemia in the Older Population.” The purpose of this workshop is to discuss the importance of individualized glycemic control targets for older patients with diabetes, in order to reduce the risk of serious hypoglycemia, identify and discuss medication safety efforts, both those that are part of the Safe Use Initiative and those external to FDA, that are of direct relevance and importance to older patients living with the disease, discuss future areas of research which could be explored to reduce the risk of serious hypoglycemia in older diabetic patients, and disseminate the results of this discussion to inform patients, patient advocates, and healthcare practitioners.
September 12, 2017
8:00 a.m. to 4:30 p.m.
FDA’s White Oak campus
10903 New Hampshire Avenue
Building 31 (The Great Room)
Silver Spring, MD 20903
To register for the public workshop, please visit the following website https://www.eventbrite.com/e/reducing-the-risk-of-preventable-adverse-drug-events-associated-with-hypoglycemia-in-the-older-tickets-33887437237
Scott Winiecki, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, (240) 402-8824, Email: CDERSafeUseInitiative@fda.hhs.gov.